Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Potential clinical and economic impact of switching branded medications to generics

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: LIU, Larry (Pfizer Inc., New York, United States of America)
  • Co-author(s): Straka, Robert (University of Minnesota College of Pharmacy, Minneapolis, United States of America)
    Keohane, Denis (Pfizer Inc., New York, United States of America)
    Liu, Larry (Pfizer Inc., New York, United States of America)
  • Abstract:

    Background information: Switching branded medications to generics is a common cost-containment practice. Although an important objective for healthcare sustainability, studies of the impact of this practice on patient outcomes are warranted.

    Setting: Literature review summarizing the potential clinical and economic impact of switching branded..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses